Praxis Precision Medicines, Inc. PRAX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s total current assets?
- Praxis Precision Medicines, Inc. (PRAX) reported total current assets of $797.77M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s total current assets changed year-over-year?
- Praxis Precision Medicines, Inc.'s total current assets increased by 139.2% year-over-year, from $333.58M to $797.77M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total current assets has grown at a 15.1% compound annual growth rate (CAGR), from $302.33M to $610.91M.
- What does total current assets mean?
- The sum of all assets that a company expects to turn into cash within one year.
- How do you interpret total current assets?
- Higher values indicate a stronger short-term liquidity position, providing a buffer for research and development expenses.
- How does total current assets compare across companies?
- Clinical-stage companies often show high current asset ratios relative to total assets due to the lack of significant revenue-generating long-term assets.